|
Antiplatelets
Citations 1-10 of 261 total displayed.
|
Most recent content
(29 Oct 2009):
|
- Articles
Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation. Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
- Raymond Chee-Seong Seet and Christopher P.L. Chen
Stroke published October 29, 2009, doi:10.1161/STROKEAHA.109.568576
[Abstract]
|
Past content
(since Jan 1999):
|
- Research Letters
Sarpogrelate Versus Aspirin in Secondary Prevention of Cerebral Infarction: Differential Efficacy in Diabetes?: Subgroup Analysis From S-ACCESS
- Yukito Shinohara, Katsuya Nishimaru for the S-ACCESS study group
Stroke 2009;40:2862-2865; published online before print as doi:10.1161/STROKEAHA.109.554246
[Abstract]
[Full text]
- Articles
Sarpogrelate Versus Aspirin in Secondary Prevention of Cerebral Infarction: Differential Efficacy in Diabetes? Subgroup Analysis From S-ACCESS
- Yukito Shinohara, Katsuya Nishimaru for the S-ACCESS study group
Stroke published June 11, 2009, doi:10.1161/STROKEAHA.109.554246
[Abstract]
- Original Contributions
Effect of Antiplatelet Therapy for Endovascular Coiling in Aneurysmal Subarachnoid Hemorrhage
- Walter M. van den Bergh, Richard S.C. Kerr, Ale Algra, Gabriel J.E. Rinkel, Andrew J. Molyneux for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group
Stroke 2009;40:1969-1972; published online before print as doi:10.1161/STROKEAHA.108.528802
[Abstract]
[Full text]
- Topical Reviews
Treatment of Atherosclerotic Intracranial Arterial Stenosis
- Tanya N. Turan, Colin P. Derdeyn, David Fiorella, and Marc I. Chimowitz
Stroke 2009;40:2257-2261; published online before print as doi:10.1161/STROKEAHA.108.537589
[Full text]
- Controversies in Stroke
Need for a Point-of-Care Assay for Monitoring Antiplatelet and Antithrombotic Therapies
- Gundu H.R. Rao
Stroke 2009;40:2271-2272; published online before print as doi:10.1161/STROKEAHA.108.537621
[Full text]
- Controversies in Stroke
Antiplatelet Activity Should Be Measured Routinely: No
- Philip M.W. Bath
Stroke 2009;40:2273-2274; published online before print as doi:10.1161/STROKEAHA.108.537647
[Full text]
- Controversies in Stroke
Antiplatelet Activity
- Stephen M. Davis and Geoffrey A. Donnan
Stroke 2009;40:2275; published online before print as doi:10.1161/STROKEAHA.108.537654
[Full text]
- Emerging Therapies
Antiplatelets for Stroke Prevention: Implications of the PRoFESS Trial
- Magdy Selim
Stroke 2009;40:1936-1937; published online before print as doi:10.1161/STROKEAHA.108.537829
[Full text]
- Articles
Antiplatelet Activity
- Stephen M. Davis and Geoffrey A. Donnan
Stroke published April 30, 2009, doi:10.1161/STROKEAHA.108.537654
[Abstract]
|
|
